Primary cutaneous marginal zone B-cell lymphomas are targeted by aberrant somatic hypermutation

Journal of Investigative Dermatology

Volumn 129, Issue 2, 2009, Pages 476-479

  Deutsch, Alexander J A ^a   Frühwirth, Margareta ^a   Aigelsreiter, Ariane ^a   Cerroni, Lorenzo ^a   Neumeister, Peter ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE PIM 1; TRANSCRIPTION FACTOR PAX5;

AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; MARGINAL ZONE LYMPHOMA; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SOMATIC HYPERMUTATION;

AMINO ACID SUBSTITUTION; B-CELL-SPECIFIC ACTIVATOR PROTEIN; DNA MUTATIONAL ANALYSIS; GENOMIC INSTABILITY; HUMANS; LYMPHOMA, B-CELL; PROTO-ONCOGENE PROTEINS C-MYC; PROTO-ONCOGENE PROTEINS C-PIM-1; RHO GTP-BINDING PROTEINS; SKIN NEOPLASMS; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TRANSCRIPTION FACTORS;

EID: 58549095869     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.243     Document Type: Article

References (25)

1. Bodor C, Bognar A, Reiniger L, Szepesi A, Toth E, Kopper L et al. (2005) Aberrant somatic hypermutation and expression of activation-induced cytidine deaminase mRNA in mediastinal large B-cell lymphoma. Br J Haematol 129:373-6
2. Cerroni L (2006) Lymphoproliferative lesions of the skin. J Clin Pathol 59:813-26
3. Cerroni L, Signoretti S, Hofler G, Annessi G, Putz B, Lackinger E et al. (1997a) Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol 21:1307-15
4. Cerroni L, Zochling N, Putz B, Kerl H (1997b) Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 24:457-61
5. Cesarman E, Dalla-Favera R, Bentley D, Groudine M (1987) Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science 238:1272-5
6. Deutsch AJ, Aigelsreiter A, Staber PB, Beham A, Linkesch W, Guelly C et al. (2007) MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation. Blood 109:3500-4
7. Dijkman R, Tensen CP, Buettner M, Niedobitek G, Willemze R, Vermeer MH (2006) Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID. Blood 107:4926-9
8. Fink-Puches R, Zenahlik P, Back B, Smolle J, Kerl H, Cerroni L (2002) Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients. Blood 99:800-5
9. Gaidano G, Pasqualucci L, Capello D, Berra E, Deambrogi C, Rossi D et al. (2003) Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood 102:1833-41
10. Halldorsdottir AM, Fruhwirth M, Deutsch A, Aigelsreiter A, Beham-Schmid C, Agnarsson BA et al. (2008) Quantifying the role of aberrant somatic hypermutation in transformation of follicular lymphoma. Leuk Res 32:1015-21
11. Küppers R, Dalla-Favera R (2001) Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20:5580-94
12. Liu M, Duke JL, Richter DJ, Vinuesa CG, Goodnow CC, Kleinstein SH et al. (2008) Two levels of protection for the B cell genome during somatic hypermutation. Nature 451:841-5
13. Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, Morisawa T et al. (2007) Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 13:470-6
14. Pasqualucci L, Bhagat G, Jankovic M, Compagno M, Smith P, Muramatsu M et al. (2008) AID is required for germinal center-derived lymphomagenesis. Nat Genet 40:108-12
15. Pasqualucci L, Migliazza A, Fracchiolla N, William C, Neri A, Baldini L et al. (1998) BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci USA 95:11816-21
16. Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RSK, Kuppers R et al. (2001) Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412:341
17. Pasqualucci LGR, Malek SN, Novak U, Compagno M, Nanjangu G, Dalla-Favera R (2004) Aberrant somatic hypermutation targets an extensive set of genes in diffuse large B-Cell lymphoma. Blood 104:428A
18. Peng H-Z, Du M-Q, Koulis A, Aiello A, Dogan A, Pan L-X et al. (1999) Nonimmunoglobulin gene hypermutation in germinal center B cells. Blood 93:2167-72
19. Raffeld M, Yano T, Hoang AT, Lewis B, Clark HM, Otsuki T et al. (1995) Clustered mutations in the transcriptional activation domain of Myc in 8q24 translocated lymphomas and their functional consequences. Curr Top Microbiol Immunol 194:265-72
20. Rijlaarsdam JU, van der Putte SC, Berti E, Kerl H, Rieger E, Toonstra J et al. (1993) Cutaneous immunocytomas: a clinicopathologic study of 26 cases. Histopathology 23:117-25
21. Rossi D, Cerri M, Capello D, Deambrogi C, Berra E, Franceschetti S et al. (2005) Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma. Leukemia 19:2363-6
22. Shen HM, Peters A, Baron B, Zhu X, Storb U (1998) Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280:1750-2
23. Storb U, Peters A, Klotz E, Kim N, Shen HM, Hackett J et al. (1998) Cis-acting sequences that affect somatic hypermutation of Ig genes. Immunol Rev 162:153-60
24. Wang CL, Harper RA, Wabl M (2004) Genome-wide somatic hypermutation. Proc Natl Acad Sci 101:7352-6
25. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH et al. (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768-85